Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient
- PMID: 7711412
- DOI: 10.1007/BF00577752
Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient
Abstract
Visceral leishmaniasis (kala-azar) affecting HIV-infected patient is being reported in increasing frequency. A 40-year-old German bisexual patient with full-blown AIDS is described who presented with Kaposi's sarcoma, epigastric pain, diarrhea, and weight loss but without fever. Leishmania amastigotes were initially found in biopsies from stomach, duodenum, and a cutaneous Kaposi's sarcoma lesion but were later also recovered from bone marrow and lymph node. The patient received three courses of a combination of pentavalent antimony and interferon-gamma. In addition to the common side effects such as fever, thrombocytopenia, and elevated amylase and lipase, a vivid progression of the Kaposi's sarcoma was noted. Tumor progression was temporally closely associated with treatment with interferon-gamma. Because this phenomenon has also been observed in other patients, we advise caution when using interferon-gamma in patients with Kaposi's sarcoma.
Similar articles
-
Visceral leishmaniasis (kala azar) in a patient with AIDS.AIDS. 1989 Jan;3(1):41-3. AIDS. 1989. PMID: 2496712
-
Kaposi's sarcoma with an intense parasitization by Leishmania.Cutis. 1996 Feb;57(2):103-5. Cutis. 1996. PMID: 8646853
-
Lympho-cutaneous Kaposi's sarcoma in an African pediatric AIDS case.Am J Trop Med Hyg. 1989 Mar;40(3):323-5. doi: 10.4269/ajtmh.1989.40.323. Am J Trop Med Hyg. 1989. PMID: 2929857
-
AIDS-associated Kaposi's sarcoma pathogenesis, clinical features, and treatment.Curr Opin Oncol. 1993 Sep;5(5):831-4. doi: 10.1097/00001622-199309000-00010. Curr Opin Oncol. 1993. PMID: 8218495 Review.
-
[Visceral leishmaniasis (kala-azar) and HIV infection. Apropos of a case and literature review].Schweiz Med Wochenschr. 1990 Mar 24;120(12):414-6. Schweiz Med Wochenschr. 1990. PMID: 2181645 Review. French.
Cited by
-
In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis.Antimicrob Agents Chemother. 1996 Nov;40(11):2447-51. doi: 10.1128/AAC.40.11.2447. Antimicrob Agents Chemother. 1996. PMID: 8913444 Free PMC article.
-
Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.Clin Microbiol Rev. 2002 Apr;15(2):310-26. doi: 10.1128/CMR.15.2.310-326.2002. Clin Microbiol Rev. 2002. PMID: 11932235 Free PMC article. Review.
-
Leishmaniasis-HIV coinfection: current challenges.HIV AIDS (Auckl). 2016 Oct 7;8:147-156. doi: 10.2147/HIV.S93789. eCollection 2016. HIV AIDS (Auckl). 2016. PMID: 27785103 Free PMC article. Review.
-
Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.Front Immunol. 2018 Jan 12;8:1943. doi: 10.3389/fimmu.2017.01943. eCollection 2017. Front Immunol. 2018. PMID: 29375567 Free PMC article. Review.
-
Leishmania and human immunodeficiency virus coinfection: the first 10 years.Clin Microbiol Rev. 1997 Apr;10(2):298-319. doi: 10.1128/CMR.10.2.298. Clin Microbiol Rev. 1997. PMID: 9105756 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical